This report was recently updated on January 2 2025 with the latest and most recent
market numbers
Global Cancer Vaccines Market Size, Trends & Analysis - Forecasts to 2029 By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, and Others), By Technology (Cell-based Vaccines, Recombinant, and Others), By Indication (Cervical Cancer, Prostrate Cancer, and Others), By End User (Hospitals, Specialty Clinics & Centers, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global cancer vaccines market is estimated to exhibit a CAGR of 8.9% from 2024 to 2029.
The primary factors propelling the market growth are the increasing global cancer incidence rates and the rising awareness and investment in cancer prevention and early detection. According to the World Health Organization (WHO), cancer remains one of the leading causes of death worldwide, with approximately 20 million new cases reported in 2023. The increasing prevalence of disease emphasizes how urgently preventive and treatment measures are needed. By encouraging the immune system to target and eliminate cancer cells, cancer vaccines present a promising strategy for lowering incidence and mortality. Preventive vaccines, such as the HPV vaccine, have demonstrated success in reducing cervical cancer cases, while therapeutic vaccines aim to treat existing cancers by boosting immune responses. As cancer rates continue to rise due to aging populations, environmental factors, and lifestyle changes, healthcare systems are prioritizing innovative strategies like vaccines to address the challenge. Increased public awareness and investment in cancer prevention further accelerate the development and adoption of cancer vaccines globally.
Government initiatives and funding for cancer research along with the growing emphasis on personalized medicine are expected to support the market growth. Governments across the world are prioritizing the development of innovative cancer prevention and treatment solutions, including vaccines, by providing substantial financial support. Research grants, subsidies, and funding programs encourage pharmaceutical companies and academic institutions to focus on vaccine development, fostering breakthroughs in both preventive and therapeutic cancer vaccines. To speed up vaccine development and clinical trials, governments are promoting cooperation between the public and commercial sectors. The significance of cancer vaccines in lowering the disease's burden is further highlighted by public health activities including awareness campaigns and immunization programs. By offering incentives like tax benefits and streamlined regulatory processes, governments enable faster commercialization and wider accessibility of cancer vaccines. For instance, During the 2023 season, the Cycle for Survival community raised USD 30 million for research on rare cancers.
Advancements in immunotherapy and vaccine technology coupled with the regulatory approvals for novel cancer vaccines propel market growth. By improving the immune system's ability to recognize and target cancer cells, advances in immunotherapy have completely changed the way that cancer is treated. These developments have paved the way for the creation of highly successful cancer vaccines, both therapeutic and preventive. Innovations in vaccine delivery platforms, such as mRNA, DNA, and viral vector technologies, are enhancing the safety, efficacy, and precision of cancer vaccines. Additionally, the integration of artificial intelligence and genomics is enabling personalized vaccine development tailored to individual patients’ tumor profiles, significantly improving treatment outcomes. Progress in adjuvant technology has further boosted immune responses, making vaccines more effective against various types of cancers.
Streamlined regulatory pathways and incentives from healthcare authorities offer opportunities for faster approvals and commercialization of cancer vaccines, boosting innovation and global market expansion. Additionally, partnerships between biotechnology firms, research institutions, and government organizations present opportunities to accelerate vaccine R&D, share resources, and bring innovative cancer vaccines to market more efficiently.
However, inadequate healthcare infrastructure and affordability issues in developing countries can impede market growth.
The preventive cancer vaccines segment is expected to hold the largest share of the market over the forecast period. Preventive cancer vaccines, such as the HPV and hepatitis B vaccines, are widely used to reduce the risk of cancers like cervical and liver cancer. Their application across diverse populations contributes to their dominance in the global cancer vaccines market.
The therapeutic cancer vaccines segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Therapeutic cancer vaccines are designed to treat advanced and metastatic cancers, addressing a critical unmet need. The increasing prevalence of late-stage cancers drives the demand for these vaccines, making this segment the fastest-growing.
The recombinant segment is expected to hold the largest share of the market over the forecast period. Recombinant technology enables the development of highly effective and safer cancer vaccines by using genetically engineered antigens. Their reliability and reduced risk of side effects make recombinant vaccines the preferred choice, ensuring their dominance in the global cancer vaccines market.
The cell-based vaccines segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Cell-based vaccines align with the growing trend toward personalized cancer treatments by using patient-derived cells to create individualized therapies. This focus is driving interest and investment in this segment.
The cervical cancer segment is expected to hold the largest share of the market over the forecast period. Cervical cancer can be prevented with vaccines like the HPV vaccine, which is quite effective in lowering the disease's incidence. Their proven track record has driven widespread adoption, solidifying the cervical cancer segment's dominance in the global market.
The prostrate cancer segment is expected to be the fastest-growing segment in the market from 2024 to 2029. A growing number of clinical trials are dedicated to developing effective prostate cancer vaccines, which are attracting significant investment from pharmaceutical companies. This surge in research and clinical testing accelerates the market growth of prostate cancer vaccines.
The hospital segment is expected to hold the largest share of the market over the forecast period. Hospitals offer a wide range of cancer care services, including diagnostic, therapeutic, and preventive treatments. This comprehensive approach includes the use of cancer vaccines as part of integrated care plans, driving hospitals’ dominance in the global cancer vaccines market.
The specialty clinics & centers segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Specialty clinics are typically early adopters of cutting-edge treatments, including innovative cancer vaccines. Their ability to quickly integrate new therapies into their treatment protocols helps fuel the rapid expansion of the specialty clinics & centers segment in the cancer vaccines market.
North America is expected to be the largest region in the global market. North America benefits from a robust regulatory framework, with agencies like the FDA providing rigorous approval processes for cancer vaccines. This ensures that safe and effective vaccines are available to the public, encouraging their widespread use and boosting market growth in the region.
Asia Pacific is anticipated to witness rapid growth during the forecast period. The rising affordability of cancer vaccines, especially as generic options and local manufacturers emerge, is making them accessible to a broader population in Asia Pacific. This cost-effectiveness is accelerating vaccine adoption, driving rapid market growth.
Merck & Co., Inc., GSK plc, Dendreon Pharmaceuticals LLC, JW CreaGene, Serum Institute of India Pvt. Ltd., Verity Pharmaceuticals, Inc., Wantai BioPharm, Vaccinogen, Shanghai Zerun Biotechnology Co., Ltd., and BioNTech SE among others, are some of the key players in the global cancer vaccines market.
Please note: This is not an exhaustive list of companies profiled in the report.
In June 2024, in a mid-stage clinical trial, Moderna and Merck & Co. claimed that their experimental cancer vaccine showed enhanced survival rates and long-lasting efficacy when combined with the popular immunotherapy Keytruda. The trial demonstrated the potential of this combination therapy to improve treatment results by concentrating on patients with advanced melanoma, a very aggressive and deadly kind of skin cancer.
In March 2024, BostonGene, NEC, and Transgene extended their partnership for the Neoantigen Cancer Vaccine TG4050 Phase I/II Clinical Trial.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL CANCER VACCINES MARKET, BY TYPE
4.1 Introduction
4.2 Cancer Vaccines Market: Technology Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Preventive Cancer Vaccines
4.4.1 Preventive Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
4.5 Therapeutic Cancer Vaccines
4.5.1 Therapeutic Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
4.6 Others
4.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Billion)
5 GLOBAL CANCER VACCINES MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Cancer Vaccines Market: Technology Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Cell-based Vaccines
5.4.1 Cell-based Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
5.5 Recombinant
5.5.1 Recombinant Market Estimates and Forecast, 2021-2029 (USD Billion)
5.6 Others
5.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Billion)
6 GLOBAL CANCER VACCINES MARKET, BY INDICATION
6.1 Introduction
6.2 Cancer Vaccines Market: Indication Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Cervical Cancer
6.4.1 Cervical Cancer Market Estimates and Forecast, 2021-2029 (USD Billion)
6.5 Prostrate Cancer
6.5.1 Prostrate Cancer Market Estimates and Forecast, 2021-2029 (USD Billion)
6.6 Others
6.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Billion)
7 GLOBAL CANCER VACCINES MARKET, BY END USER
7.1 Introduction
7.2 Cancer Vaccines Market: End User Scope Key Takeaways
7.3 Revenue Growth Analysis, 2023 & 2029
7.4 Hospitals
7.4.1 Hospitals Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5 Specialty Clinics & Centers
7.5.1 Specialty Clinics & Centers Market Estimates and Forecast, 2021-2029 (USD Billion)
7.6 Others
7.6.1 Others Market Estimates and Forecast, 2021-2029 (USD Billion)
8 GLOBAL CANCER VACCINES MARKET, BY REGION
8.1 Introduction
8.2 North America Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.1 By Type
8.2.2 By Technology
8.2.3 By Indication
8.2.4 By End User
8.2.5 By Country
8.2.5.1 U.S. Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.1.1 By Type
8.2.5.1.2 By Technology
8.2.5.1.3 By Indication
8.2.5.1.4 By End User
8.2.5.2 Canada Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.2.1 By Type
8.2.5.2.2 By Technology
8.2.5.2.3 By Indication
8.2.5.2.4 By End User
8.2.5.3 Mexico Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.2.5.3.1 By Type
8.2.5.3.2 By Technology
8.2.5.3.3 By Indication
8.2.5.3.4 By End User
8.3 Europe Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.1 By Type
8.3.2 By Technology
8.3.3 By Indication
8.3.4 By End User
8.3.5 By Country
8.3.5.1 Germany Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.1.1 By Type
8.3.5.1.2 By Technology
8.3.5.1.3 By Indication
8.3.5.1.4 By End User
8.3.5.2 U.K. Presered Flowers Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.2.1 By Type
8.3.5.2.2 By Technology
8.3.5.2.3 By Indication
8.3.5.2.4 By End User
8.3.5.3 France Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.3.1 By Type
8.3.5.3.2 By Technology
8.3.5.3.3 By Indication
8.3.5.3.4 By End User
8.3.5.4 Italy Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.4.1 By Type
8.3.5.4.2 By Technology
8.3.5.4.3 By Indication
8.3.5.4.4 By End User
8.3.5.5 Spain Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.5.1 By Type
8.3.5.5.2 By Technology
8.3.5.5.3 By Indication
8.3.5.5.4 By End User
8.3.5.6 Netherlands Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.6.1 By Type
8.3.5.6.2 By Technology
8.3.5.6.3 By Indication
8.3.5.6.4 By End User
8.3.5.7 Rest of Europe Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.3.5.7.1 By Type
8.3.5.7.2 By Technology
8.3.5.7.3 By Indication
8.3.5.7.4 By End User
8.4 Asia Pacific Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.1 By Type
8.4.2 By Technology
8.4.3 By Indication
8.4.4 By End User
8.4.5 By Country
8.4.5.1 China Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.1.1 By Type
8.4.5.1.2 By Technology
8.4.5.1.3 By Indication
8.4.5.1.4 By End User
8.4.5.2 Japan Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.2.1 By Type
8.4.5.2.2 By Technology
8.4.5.2.3 By Indication
8.4.5.2.4 By End User
8.4.5.3 India Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.3.1 By Type
8.4.5.3.2 By Technology
8.4.5.3.3 By Indication
8.4.5.3.4 By End User
8.4.5.4 South Korea Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.4.1 By Type
8.4.5.4.2 By Technology
8.4.5.4.3 By Indication
8.4.5.4.4 By End User
8.4.5.5 Singapore Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.5.1 By Type
8.4.5.5.2 By Technology
8.4.5.5.3 By Indication
8.4.5.5.4 By End User
8.4.5.6 Malaysia Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.6.1 By Type
8.4.5.6.2 By Technology
8.4.5.6.3 By Indication
8.4.5.6.4 By End User
8.4.5.7 Thailand Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.7.1 By Type
8.4.5.7.2 By Technology
8.4.5.7.3 By Indication
8.4.5.7.4 By End User
8.4.5.8 Indonesia Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.8.1 By Type
8.4.5.8.2 By Technology
8.4.5.8.3 By Indication
8.4.5.8.4 By End User
8.4.5.9 Vietnam Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.9.1 By Type
8.4.5.9.2 By Technology
8.4.5.9.3 By Indication
8.4.5.9.4 By End User
8.4.5.10 Taiwan Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.10.1 By Type
8.4.5.10.2 By Technology
8.4.5.10.3 By Indication
8.4.5.10.4 By End User
8.4.5.11 Rest of Asia Pacific Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.4.5.11.1 By Type
8.4.5.11.2 By Technology
8.4.5.11.3 By Indication
8.4.5.11.4 By End User
8.5 Middle East and Africa Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.1 By Type
8.5.2 By Technology
8.5.3 By Indication
8.5.4 By End User
8.5.5 By Country
8.5.5.1 Saudi Arabia Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.1.1 By Type
8.5.5.1.2 By Technology
8.5.5.1.3 By Indication
8.5.5.1.4 By End User
8.5.5.2 U.A.E. Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.2.1 By Type
8.5.5.2.2 By Technology
8.5.5.2.3 By Indication
8.5.5.2.4 By End User
8.5.5.3 Israel Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.4.3.1 By Type
8.5.4.3.2 By Technology
8.5.4.3.3 By Indication
8.5.5.3.4 By End User
8.5.5.4 South Africa Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.4.1 By Type
8.5.5.4.2 By Technology
8.5.5.4.3 By Indication
8.5.5.4.4 By End User
8.5.5.5 Rest of Middle East and Africa Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.5.5.5.1 By Type
8.5.5.5.2 By Technology
8.5.5.5.2 By Indication
8.5.5.5.4 By End User
8.6 Central & South America Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.1 By Type
8.6.2 By Technology
8.6.3 By Indication
8.6.4 By End User
8.6.5 By Country
8.6.5.1 Brazil Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.1.1 By Type
8.6.5.1.2 By Technology
8.6.5.1.3 By Indication
8.6.5.1.4 By End User
8.6.5.2 Argentina Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.2.1 By Type
8.6.5.2.2 By Technology
8.6.5.2.3 By Indication
8.6.5.2.4 By End User
8.6.5.3 Chile Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.3.1 By Type
8.6.5.3.2 By Technology
8.6.5.3.3 By Indication
8.6.5.5.4 By End User
8.6.5.4 Rest of Central & South America Cancer Vaccines Market Estimates and Forecast, 2021-2029 (USD Billion)
8.6.5.4.1 By Type
8.6.5.4.2 By Technology
8.6.5.4.3 By Indication
8.6.5.4.4 By End User
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 Merck & Co., Inc.
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 GSK plc
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 Dendreon Pharmaceuticals LLC
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 JW CreaGene
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Serum Institute of India Pvt. Ltd.
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 VERITY PHARMACEUTICALS, INC.
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 Wantai BioPharm
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 Vaccinogen
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 Shanghai Zerun Biotechnology Co., Ltd.
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 BioNTech SE
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
9.4.11 Other Companies
9.4.11.1 Business Description & Financial Analysis
9.4.11.2 SWOT Analysis
9.4.11.3 Products & Services Offered
9.4.11.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
2 Preventive Cancer Vaccines Market, By Region, 2021-2029 (USD Billion)
3 Therapeutic Cancer Vaccines Market, By Region, 2021-2029 (USD Billion)
4 Others Market, By Region, 2021-2029 (USD Billion)
5 Global Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
6 Cell-based Vaccines Market, By Region, 2021-2029 (USD Billion)
7 Recombinant Market, By Region, 2021-2029 (USD Billion)
8 Others Market, By Region, 2021-2029 (USD Billion)
9 Global Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
10 Cervical Cancer Market, By Region, 2021-2029 (USD Billion)
11 Prostrate Cancer Market, By Region, 2021-2029 (USD Billion)
12 Others Market, By Region, 2021-2029 (USD Billion)
13 Global Cancer Vaccines Market, By END USER, 2021-2029 (USD Billion)
14 Hospitals Market, By Region, 2021-2029 (USD Billion)
15 Specialty Clinics & Centers Market, By Region, 2021-2029 (USD Billion)
16 Others Market, By Region, 2021-2029 (USD Billion)
17 Regional Analysis, 2021-2029 (USD Billion)
18 North America Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
19 North America Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
20 North America Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
21 North America Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
22 North America Cancer Vaccines Market, By Country, 2021-2029 (USD Billion)
23 U.S Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
24 U.S Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
25 U.S Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
26 U.S Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
27 Canada Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
28 Canada Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
29 Canada Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
30 CANADA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
31 Mexico Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
32 Mexico Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
33 Mexico Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
34 mexico Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
35 Europe Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
36 Europe Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
37 Europe Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
38 europe Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
39 europe Cancer Vaccines Market, By COUNTRY, 2021-2029 (USD Billion)
40 Germany Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
41 Germany Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
42 Germany Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
43 germany Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
44 UK Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
45 UK Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
46 UK Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
47 U.k Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
48 France Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
49 France Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
50 France Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
51 France Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
52 Italy Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
53 Italy Cancer Vaccines Market, By T Technology Type, 2021-2029 (USD Billion)
54 Italy Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
55 italy Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
56 Spain Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
57 Spain Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
58 Spain Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
59 spain Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
60 Netherlands Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
61 Netherlands Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
62 Netherlands Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
63 Netherlands Cancer Vaccines Market, By END USER, 2021-2029 (USD Billion)
64 Rest Of Europe Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
65 Rest Of Europe Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
66 Rest of Europe Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
67 REST OF EUROPE Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
68 Asia Pacific Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
69 Asia Pacific Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
70 Asia Pacific Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
71 asia Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
72 Asia Pacific Cancer Vaccines Market, By Country, 2021-2029 (USD Billion)
73 China Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
74 China Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
75 China Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
76 china Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
77 India Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
78 India Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
79 India Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
80 india Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
81 Japan Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
82 Japan Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
83 Japan Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
84 japan Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
85 South Korea Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
86 South Korea Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
87 South Korea Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
88 south korea Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
89 Singapore Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
90 Singapore Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
91 Singapore Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
92 Singapore Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
93 Thailand Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
94 Thailand Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
95 Thailand Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
96 Thailand Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
97 MALAYSIA Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
98 MALAYSIA Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
99 MALAYSIA Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
100 MALAYSIA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
101 Vietnam Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
102 Vietnam Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
103 Vietnam Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
104 Taiwan Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
105 Taiwan Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
106 Taiwan Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
107 Taiwan Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
108 REST OF APAC Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
109 REST OF APAC Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
110 REST OF APAC Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
111 Rest of APAC Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
112 Middle East and Africa Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
113 Middle East and Africa Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
114 Middle East and Africa Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
115 MIDDLE EAST AND AFRICA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
116 Middle East and Africa Cancer Vaccines Market, By Country, 2021-2029 (USD Billion)
117 Saudi Arabia Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
118 Saudi Arabia Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
119 Saudi Arabia Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
120 saudi arabia Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
121 UAE Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
122 UAE Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
123 UAE Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
124 uae Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
125 Israel Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
126 Israel Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
127 Israel Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
128 Israel Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
129 South Africa Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
130 South Africa Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
131 South Africa Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
132 South Africa Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
133 REST OF MIDDLE EAST AND AFRICA Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
134 REST OF MIDDLE EAST AND AFRICA Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
135 REST OF MIDDLE EAST AND AFRICA Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
136 REST OF MIDDLE EAST AND AFRICA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
137 Central & South America Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
138 Central & South America Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
139 Central & South America Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
140 CENTRAL & SOUTH AMERICA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
141 Central & South America Cancer Vaccines Market, By Country, 2021-2029 (USD Billion)
142 Brazil Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
143 Brazil Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
144 Brazil Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
145 brazil Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
146 Chile Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
147 Chile Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
148 Chile Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
149 Chile Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
150 Argentina Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
151 Argentina Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
152 Argentina Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
153 Argentina Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
154 REST OF CENTRAL AND SOUTH AMERICA Cancer Vaccines Market, By Type, 2021-2029 (USD Billion)
155 REST OF CENTRAL AND SOUTH AMERICA Cancer Vaccines Market, By Technology, 2021-2029 (USD Billion)
156 REST OF CENTRAL AND SOUTH AMERICA Cancer Vaccines Market, By Indication, 2021-2029 (USD Billion)
157 REST OF CENTRAL AND SOUTH AMERICA Cancer Vaccines Market, By End User, 2021-2029 (USD Billion)
158 Merck & Co., Inc.: Products & Services Offering
159 GSK plc: Products & Services Offering
160 Dendreon Pharmaceuticals LLC: Products & Services Offering
161 JW CreaGene: Products & Services Offering
162 Serum Institute of India Pvt. Ltd.: Products & Services Offering
163 VERITY PHARMACEUTICALS, INC.: Products & Services Offering
164 Wantai BioPharm: Products & Services Offering
165 Vaccinogen: Products & Services Offering
166 Shanghai Zerun Biotechnology Co., Ltd., Inc: Products & Services Offering
167 BioNTech SE: Products & Services Offering
168 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Cancer Vaccines Market Overview
2 Global Cancer Vaccines Market Value From 2021-2029 (USD Billion)
3 Global Cancer Vaccines Market Share, By Type (2023)
4 Global Cancer Vaccines Market Share, By Technology (2023)
5 Global Cancer Vaccines Market Share, By Indication (2023)
6 Global Cancer Vaccines Market Share, By End User (2023)
7 Global Cancer Vaccines Market, By Region (Asia Pacific Market)
8 Technological Trends In Global Cancer Vaccines Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global Cancer Vaccines Market
12 Impact Of Challenges On The Global Cancer Vaccines Market
13 Porter’s Five Forces Analysis
14 Global Cancer Vaccines Market: By Type Scope Key Takeaways
15 Global Cancer Vaccines Market, By Type Segment: Revenue Growth Analysis
16 Preventive Cancer Vaccines Market, By Region, 2021-2029 (USD Billion)
17 Therapeutic Cancer Vaccines Market, By Region, 2021-2029 (USD Billion)
18 Others Market, By Region, 2021-2029 (USD Billion)
19 Global Cancer Vaccines Market: By Technology Scope Key Takeaways
20 Global Cancer Vaccines Market, By Technology Segment: Revenue Growth Analysis
21 Cell-based Vaccines Market, By Region, 2021-2029 (USD Billion)
22 Recombinant Market, By Region, 2021-2029 (USD Billion)
23 Others Market, By Region, 2021-2029 (USD Billion)
24 Global Cancer Vaccines Market: By Indication Scope Key Takeaways
25 Global Cancer Vaccines Market, By Indication Segment: Revenue Growth Analysis
26 Cervical Cancer Market, By Region, 2021-2029 (USD Billion)
27 Prostrate Cancer Market, By Region, 2021-2029 (USD Billion)
28 Others Market, By Region, 2021-2029 (USD Billion)
29 Global Cancer Vaccines Market: By End User Scope Key Takeaways
30 Global Cancer Vaccines Market, By End User Segment: Revenue Growth Analysis
31 Hospitals Market, By Region, 2021-2029 (USD Billion)
32 Specialty Clinics & Centers Market, By Region, 2021-2029 (USD Billion)
33 Others Market, By Region, 2021-2029 (USD Billion)
34 Regional Segment: Revenue Growth Analysis
35 Global Cancer Vaccines Market: Regional Analysis
36 North America Cancer Vaccines Market Overview
37 North America Cancer Vaccines Market, By Type
38 North America Cancer Vaccines Market, By Technology
39 North America Cancer Vaccines Market, By Indication
40 North America Cancer Vaccines Market, By End User
41 North America Cancer Vaccines Market, By Country
42 U.S. Cancer Vaccines Market, By Type
43 U.S. Cancer Vaccines Market, By Technology
44 U.S. Cancer Vaccines Market, By Indication
45 U.S. Cancer Vaccines Market, By End User
46 Canada Cancer Vaccines Market, By Type
47 Canada Cancer Vaccines Market, By Technology
48 Canada Cancer Vaccines Market, By Indication
49 Canada Cancer Vaccines Market, By End User
50 Mexico Cancer Vaccines Market, By Type
51 Mexico Cancer Vaccines Market, By Technology
52 Mexico Cancer Vaccines Market, By Indication
53 Mexico Cancer Vaccines Market, By End User
54 Four Quadrant Positioning Matrix
55 Company Market Share Analysis
56 Merck & Co., Inc.: Company Snapshot
57 Merck & Co., Inc.: SWOT Analysis
58 Merck & Co., Inc.: Geographic Presence
59 GSK plc: Company Snapshot
60 GSK plc: SWOT Analysis
61 GSK plc: Geographic Presence
62 Dendreon Pharmaceuticals LLC: Company Snapshot
63 Dendreon Pharmaceuticals LLC: SWOT Analysis
64 Dendreon Pharmaceuticals LLC: Geographic Presence
65 JW CreaGene: Company Snapshot
66 JW CreaGene: Swot Analysis
67 JW CreaGene: Geographic Presence
68 Serum Institute of India Pvt. Ltd.: Company Snapshot
69 Serum Institute of India Pvt. Ltd.: SWOT Analysis
70 Serum Institute of India Pvt. Ltd.: Geographic Presence
71 VERITY PHARMACEUTICALS, INC.: Company Snapshot
72 VERITY PHARMACEUTICALS, INC.: SWOT Analysis
73 VERITY PHARMACEUTICALS, INC.: Geographic Presence
74 Wantai BioPharm : Company Snapshot
75 Wantai BioPharm : SWOT Analysis
76 Wantai BioPharm : Geographic Presence
77 Vaccinogen: Company Snapshot
78 Vaccinogen: SWOT Analysis
79 Vaccinogen: Geographic Presence
80 Shanghai Zerun Biotechnology Co., Ltd., Inc.: Company Snapshot
81 Shanghai Zerun Biotechnology Co., Ltd., Inc.: SWOT Analysis
82 Shanghai Zerun Biotechnology Co., Ltd., Inc.: Geographic Presence
83 BioNTech SE: Company Snapshot
84 BioNTech SE: SWOT Analysis
85 BioNTech SE: Geographic Presence
86 Other Companies: Company Snapshot
87 Other Companies: SWOT Analysis
88 Other Companies: Geographic Presence
The Global Cancer Vaccines Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Cancer Vaccines Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
